LEADER 04422nam 2200589 450 001 9910465946303321 005 20200520144314.0 010 $a1-60650-684-6 035 $a(CKB)3710000000610777 035 $a(OCoLC)945180204 035 $a(CaBNvSL)swl00406302 035 $a(MiAaPQ)EBC4432251 035 $a(Au-PeEL)EBL4432251 035 $a(CaPaEBR)ebr11169569 035 $a(CaONFJC)MIL901613 035 $a(OCoLC)945612332 035 $a(EXLCZ)993710000000610777 100 $a20190123d2018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aAircraft performance and sizing$hVolume I $efundamentals of aircraft performance /$fTimothy Takahashi 210 1$aNew York, NY :$cMomentum Press,$d[2018] 210 4$dİ2018 215 $a1 online resource (xvi, 230 pages) $cillustrations 225 1 $aAerospace engineering collection 311 $a1-60650-683-8 320 $aIncludes bibliographical references and index. 327 $a1. Introduction -- 1.1 Defining a clean-sheet design -- 1.2 Aircraft purpose, the explicit requirements -- 1.3 Certification, the implied requirements -- 327 $a2. Flight mechanics basics -- 2.1 Reference units -- 2.2 Coordinate frames -- 2.3 Standard atmosphere -- 2.4 How pilots actually fly airplanes -- 327 $a3. Propulsion system design drivers and performance -- 3.1 Gas turbine fundamentals -- 3.2 Calculating thrust and fuel flow -- 3.3 Propulsion system components and design drivers -- 3.4 Example engine performance data -- 327 $a4. Aerodynamic analysis fundamentals: lift and drag -- 4.1 Full configuration drag estimation -- 4.2 Zero-lift drag at incompressible speeds -- 4.3 Zero-lift drag due to compressibility -- 4.4 Drag due to lift at incompressible speeds -- 4.5 Drag due to lift arising from compressibility -- 4.6 "Crud drag," the drag of real versus idealized aerostructures -- 4.7 Maximum lift coefficient/buffet boundary -- 4.8 Angle of attack -- 4.9 Take-off, approach, and landing aerodynamics -- 327 $a5. Kinematic "point-performance" principles -- 5.1 Standard atmosphere revisited -- 5.2 Computing stall speed -- 5.3 Minimum and maximum permissible flight speeds -- 5.4 The energy-maneuverability skymap plot -- 5.5 Inferring lift and drag in an E-M plot -- 5.6 Aerodynamic efficiency (L/D) and performance efficiency (M(L/D)) -- 5.7 Dimensionalizing drag -- 5.8 Propulsive performance -- 5.9 Specific excess thrust and linear acceleration capability -- 5.10 Specific excess power, rate of climb (R.O.C.), and ceiling -- 5.11 Specific range -- 5.12 Loiter -- 5.13 Induced drag fraction of total drag for level flight limited by aerodynamics and propulsion -- 5.14 Maximum load factor, instantaneous turn rate and stall speed ratio -- 5.15 Combat agility, maximum sustained turn rate -- 327 $a6. Mission performance principles -- 6.1 Breguet range equation -- 6.2 Time-step integrating simulations -- 6.3 Creating missions using a mission simulation code -- 6.4 Observations examining the output of a mission simulation code -- 6.5 Creating trade studies using a mission simulation code -- 6.6 Creating payload/range charts using a mission simulation code -- Index. 330 3 $aThis book is a concise practical treatise for the student or experienced professional aircraft designer. This volume comprises key fundamental subjects for aerodynamic performance analysis: the basics of flight mechanics bridging both engineering and piloting perspectives, propulsion system performance attributes, practical drag prediction methods, aircraft "up and away" flight performance and aircraft mission performance. This book may serve as a textbook for an undergraduate aircraft performance course or as a reference for the classically trained practicing engineer. 410 0$aAerospace engineering collection. 606 $aAirplanes$xDesign and construction 606 $aAirplanes$xPerformance 608 $aElectronic books. 615 0$aAirplanes$xDesign and construction. 615 0$aAirplanes$xPerformance. 676 $a629.1341 700 $aTakahashi$b Timothy$0881148 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910465946303321 996 $aAircraft performance and sizing$91967917 997 $aUNINA LEADER 04474nam 22005655 450 001 9910293152703321 005 20251113184415.0 010 $a981-10-8216-2 024 7 $a10.1007/978-981-10-8216-0 035 $a(CKB)3850000000032869 035 $a(MiAaPQ)EBC5448081 035 $a(DE-He213)978-981-10-8216-0 035 $a(PPN)229499821 035 $a(EXLCZ)993850000000032869 100 $a20180703d2017 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAnticancer Plants: Clinical Trials and Nanotechnology $eVolume 3 /$fedited by Mohd Sayeed Akhtar, Mallappa Kumara Swamy 205 $a1st ed. 2017. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2017. 215 $a1 online resource (331 pages) 311 08$a981-10-8215-4 327 $aChapter 1. Cancer therapies: Current scenario, management and safety aspects -- Chapter 2. Nano-natural products as anticancer agents -- Chapter 3. Natural anticancer compounds and their derivatives in clinical trials -- Chapter 4. Insight approaches of medicinal plants for the discovery of anticancer drugs -- Chapter 5. Designing of natural cancerous drugs and their delivery system -- Chapter 6. Applications of nano based novel drug delivery systems in herbal medicine mediated cancer therapy -- Chapter 7. Toxicological and pharmacological use of anticancer compounds -- Chapter 8. Recent advancements in the clinical evaluation of plant derived anticancer compounds -- Chapter 9. Organosulfur compounds of garlic as potent chemotherapeutic agents against cancer -- Chapter 10. Relevance of traditional unani (Greco-Arab) System of medicine in cancer: An update -- Chapter 11. Signaling pathways of anticancer plants: Action and reaction. 330 $aCancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer. Plants such as Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol, podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine etc. have been isolated and purified from these medicinal plants. Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using plant tissue culture. Alternatively, plant cell tissue and organ culture biotechnology could be adopted to produce these anticancer compounds without the need for cultivation. A better grasp and continuing exploration of these isolated molecules and products could provide a powerful alternative means of reducing cancer risk. ?Anticancer Plants: Volume 3, Clinical Trials and Nanotechnology? provides a timely review of concepts and experimental data on the application of anticancer plants and their compounds in clinical trials, and on the use of nanotechnology in cancer therapy. 606 $aPlant physiology 606 $aProteins 606 $aAgriculture 606 $aPlant genetics 606 $aPlant Physiology 606 $aProtein Biochemistry 606 $aAgriculture 606 $aPlant Genetics 615 0$aPlant physiology. 615 0$aProteins. 615 0$aAgriculture. 615 0$aPlant genetics. 615 14$aPlant Physiology. 615 24$aProtein Biochemistry. 615 24$aAgriculture. 615 24$aPlant Genetics. 676 $a615.321 702 $aAkhtar$b Mohd. Sayeed$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aKumara Swamy$b Mallappa$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910293152703321 996 $aAnticancer Plants: Clinical Trials and Nanotechnology$91954774 997 $aUNINA